Berta Mosleh

6PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer diagnosisMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Impact of Residual Mediastinal Nodal Disease After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer.

|May 04, 2026
MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

|Jan 28, 2026
Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.

Muhammad Hashim, Gerald Timelthaler, Dominik Kirchhofer

|Jul 12, 2025
Management and Outcomes of Pulmonary Nodules in a Real-World Setting.

Berta Mosleh, Pavla Sarova, Helmut Prosch

|Apr 26, 2025
The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.

Berta Mosleh, Katharina Sinn, Anna Cho

|Mar 11, 2025
Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma.

Berta Mosleh, Stefan Schwarz, Anna Cho

Pageof 1

Frequent Collaborators

5 joint publications

Mir Alireza Hoda

4 joint publications

Joachim Widder

4 joint publications

Clemens Aigner

3 joint publications

Helmut Prosch